WHO ICTRP trial
A Randomized & Observational phase II trial comparing the activity of…
CTIS2024-513820-40-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-513820-40-00 |
|---|---|
| Public title | A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapy |
| Scientific title | A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapy |
| Primary sponsor | Italian Sarcoma Group |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Italy |
| Conditions | Metastatic or locally advanced leiomyosarcoma MedDRA version: 21.1Level: PTClassification code: 10024189Term: Leiomyosarcoma Class: 100000004864 MedDRA version: 20.0Level: PTClassification code: 10024191Term: Leiomyosarcoma metastatic… |
| Interventions | Product Name: Gemcitabina Accord 100 mg/ml concentrato per soluzione per infusione., Product Code:PRD3332928, Pharmaceutical Form: SOLUTION FOR INFUSION, Other descriptive name: , Strength: , Product Name: Yondelis 0.25 mg powder for… |
| Registration date | Apr 29, 2024 |
| Target size | 100 |
| Secondary IDs | NCT04383119;2020-000741-13 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: